Table 2.
AVF patency in Gender | aspirin (%) | p - value | dipyridamol (%) | p-value | control (%) |
---|---|---|---|---|---|
Female | 58/78 (74.4%) | 0.2028 | 50/65 (76.9%) | 0.2671 | 41/65 (63%) |
Male | 40/52 (76.9%) | 0.8463 | 48/65 (73.8%) | 0.9515 | 49/65 (75.4%) |
AVF patency in Gender | aspirin (%) | p - value | dipyridamol (%) | p-value | control (%) |
---|---|---|---|---|---|
Female | 58/78 (74.4%) | 0.2028 | 50/65 (76.9%) | 0.2671 | 41/65 (63%) |
Male | 40/52 (76.9%) | 0.8463 | 48/65 (73.8%) | 0.9515 | 49/65 (75.4%) |